Aspirin and tension-type headache
Acetylsalicylic acid (ASA, Aspirin) is among the most used drugs worldwide. At present, Aspirin represents a quite versatile drug employed in the control of pain symptomatologies and in situations such as prevention of both ischaemic stroke and cardiovascular events. Aspirin causes inhibition of pro...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer-Verlag
2007
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476118/ |
| id |
pubmed-3476118 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-34761182012-11-29 Aspirin and tension-type headache Farinelli, I. Martelletti, P. Rapid Communication Acetylsalicylic acid (ASA, Aspirin) is among the most used drugs worldwide. At present, Aspirin represents a quite versatile drug employed in the control of pain symptomatologies and in situations such as prevention of both ischaemic stroke and cardiovascular events. Aspirin causes inhibition of prostaglandin (PG) synthesis by inactivation of the cyclooxygenase (COX) enzyme. ASA constitutes the focus of new researches explaining more widely Aspirin’s control of inflammation. The induction of the endogenous epimers lipoxins (Aspirin-triggered 15-epi-lipoxins, ATLs) represents one of the most recent achievements. This particular feature of Aspirin is not shared by other NSAIDs. ASA is well known as a headache medication, figuring as a possible treatment choice in tension-type headache but also in acute migraine attacks. Furthermore, a new Aspirin formulation with a greater rapidity of action has been introduced. In conclusion, little information exists on the subject and more studies are required. Springer-Verlag 2007-01-02 2007-02 /pmc/articles/PMC3476118/ /pubmed/17192817 http://dx.doi.org/10.1007/s10194-006-0357-4 Text en © Springer-Verlag Italia 2007 |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Farinelli, I. Martelletti, P. |
| spellingShingle |
Farinelli, I. Martelletti, P. Aspirin and tension-type headache |
| author_facet |
Farinelli, I. Martelletti, P. |
| author_sort |
Farinelli, I. |
| title |
Aspirin and tension-type headache |
| title_short |
Aspirin and tension-type headache |
| title_full |
Aspirin and tension-type headache |
| title_fullStr |
Aspirin and tension-type headache |
| title_full_unstemmed |
Aspirin and tension-type headache |
| title_sort |
aspirin and tension-type headache |
| description |
Acetylsalicylic acid
(ASA, Aspirin) is among the most
used drugs worldwide. At present,
Aspirin represents a quite versatile
drug employed in the control of
pain symptomatologies and in situations
such as prevention of both
ischaemic stroke and cardiovascular
events. Aspirin causes inhibition
of prostaglandin (PG) synthesis by
inactivation of the cyclooxygenase
(COX) enzyme. ASA constitutes
the focus of new researches
explaining more widely Aspirin’s
control of inflammation. The
induction of the endogenous
epimers lipoxins (Aspirin-triggered
15-epi-lipoxins, ATLs) represents
one of the most recent achievements.
This particular feature of
Aspirin is not shared by other
NSAIDs. ASA is well known as a
headache medication, figuring as a
possible treatment choice in tension-type headache but also in
acute migraine attacks.
Furthermore, a new Aspirin formulation
with a greater rapidity of
action has been introduced. In conclusion,
little information exists on
the subject and more studies are
required. |
| publisher |
Springer-Verlag |
| publishDate |
2007 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476118/ |
| _version_ |
1611917530711982080 |